semaglutide nih A new clinical trial supported by the National Institutes of Health (NIH) found that a medication commonly used for weight loss, such as semaglutide, may also help reduce heavy drinking in individuals In a recent study conducted

Animal data indicating altered placental vascularization and fetal growth raise the possibility of early developmental effects, but these findings require human validation [25]

Individuals with Medicare who wish to participate in the PAP must submit their applications by November 30th annually

Additionally, its typically not prescribed for those who are pregnant, trying to become pregnant, or breastfeeding

Contact your GP if you experience increased urination with excessive thirst, unexplained weight loss, pain or burning when urinating, cloudy or bloody urine, or symptoms of dehydration, as these may indicate inadequate diabetes control or other conditions requiring investigation

Only inject under the skin (subcutaneously)

& Ho, K